Awaiting the outcome of the Patient Capital Review with an eagerness that borders on, well, impatience, Ian Battersby wonders how financial advisers will be expected to embrace whatever new rules emerge
The results of the Patient Capital Review are eagerly anticipated by tax-advantaged product providers, advisers and investors alike but, at the present time, there is very little clarity about what might...
Follows Brexit white paper
Fears of bond bear market
What made financial headlines over the weekend?
‘Gareth Southgate Wealth Management’
Questions raised over govt role in dashboard